US Patent

US9040518 — Chemical compounds

Composition of Matter · Assigned to GlaxoSmithKline LLC · Expires 2031-09-06 · 5y remaining

Vulnerability score 23/100 Ironclad — strong claim type, well-established, deep family

What this patent protects

This patent discloses chemical compounds of Formula I for treating metabolic disorders.

USPTO Abstract

Compounds of Formula I and methods for treating metabolic disorders are disclosed.

Drugs covered by this patent

Patent Metadata

Patent number: US9040518
Jurisdiction: US
Classification: Composition of Matter
Expires: 2031-09-06
Drug substance claim: Yes
Drug product claim: Yes
Assignee: GlaxoSmithKline LLC
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.